OTC:VRBCF Virbac (VRBCF) Stock Price, News & Analysis $339.23 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlines About Virbac Stock (OTC:VRBCF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Virbac alerts:Sign Up Key Stats Today's Range$339.23▼$339.2350-Day Range$339.23▼$382.0052-Week Range$339.23▼$383.52VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E Ratio51.29Dividend Yield0.56%Price TargetN/AConsensus RatingN/A Company OverviewVirbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.Read More… Receive VRBCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virbac and its competitors with MarketBeat's FREE daily newsletter. Email Address VRBCF Stock News HeadlinesKepler Capital Reaffirms Their Hold Rating on Virbac SA (0NM7)January 19 at 3:12 AM | markets.businessinsider.comVirbac: Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)January 16, 2025 | globenewswire.comTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launched a $1.9 trillion move against the Fed. What comes next could have dramatic consequences.January 22, 2025 | Stansberry Research (Ad)Virbac : Declaration of the number of shares and votiJanuary 10, 2025 | globenewswire.comVirbac : Declaration of the number of shares and voting rights 11/2024December 7, 2024 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 10/2024November 7, 2024 | finance.yahoo.comVirbac SA (0NM7) Receives a Hold from JefferiesOctober 20, 2024 | markets.businessinsider.comVirbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.October 17, 2024 | globenewswire.comSee More Headlines VRBCF Stock Analysis - Frequently Asked Questions How have VRBCF shares performed this year? Virbac's stock was trading at $339.23 at the beginning of 2025. Since then, VRBCF stock has increased by 0.0% and is now trading at $339.23. View the best growth stocks for 2025 here. How do I buy shares of Virbac? Shares of VRBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Drug Manufacturers - General Sub-IndustryN/A Current SymbolOTC:VRBCF CUSIPN/A CIKN/A Webwww.virbac.fr Phone33.4.92.08.71.00FaxN/AEmployees5,459Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio51.29 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (OTC:VRBCF) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virbac SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Virbac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
